(R)-1-(2-METHYL-1,3-DIOXOLAN-2-YL)-N-(1-PHENYLETHYL)CYCLOPROPANECARBOXAMIDE, 95.0%, 100mg

N1,N1,N2,N2-Tetrakis((6-methyl-1H-benzo[d]imidazol-2-yl)methyl)ethane-1,2-diamine, 98%, 5mg

4-(Methylamino)methylphenol, 95.0%, 1g

7-Chloro-5-cyclopropyl-[1,2,4]triazolo[1,5-a]pyrimidine, 97%, 5g

1H-INDAZOLE-7-BORONIC ACID, 95%, 5g

4-amino-N-(2,6-dimethylphenyl)benzamide, 95.0%, 5g

Boc-N-Me-Val-OH, 95.0%, 5g

(R)-METHYL 8-AMINO-5,6,7,8-TETRAHYDRONAPHTHALENE-2-CARBOXYLATE HCL, 95.0%, 250mg

1-(4-Bromo-benzyl)-1H-pyrazole-4-carboxylic acid ethyl ester, 95.0%, 1g

1-(1-Methoxypropan-2-yl)piperazine dihydrochloride, 95.0%, 5g

8-Bromo-1-chlorodibenzo[b,d]furan, 97%, 100g

Ranitidine Hydrochloride>98.0%(HPLC)(T)5g

N-Methyl-3-phenylbicyclo[1.1.1]pentan-1-amine hydrobromide, 95+%, 100mg